By contrast, MACE risk was significantly lower among those who continued GLP-1RA use for 2 and 2.5 years, and lowest among those who maintained treatment for three years
102 Bloch SA, Lee JY, Syburra T, Rosendahl U, Griffiths MJ, Kemp PR, Polkey MI
Consider establishing an objective monitoring plan around GLP-1 initiation, including baseline and follow-up inflammatory markers (C-reactive protein, fecal calprotectin) and maintaining a symptom diary to help differentiate medication side effects from disease activity
FAQs How quickly will I lose weight with medical weight loss
By bypassing the digestive system, IV therapy may provide a temporary boost in nutrient levels, supporting cellular regeneration and potentially enhancing the skins natural glow